Clinical trials
Prostatic Neoplasms trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 12 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 18 |
| 2022 | 16 |
| 2023 | 17 |
| 2024 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 109 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 9 |
| Fudan University | 6 |
| Anhui Provincial Hospital | 5 |
| Peking Union Medical College Hospital | 5 |
| Qilu Hospital of Shandong University | 5 |
| RenJi Hospital | 5 |
| Shanghai East Hospital | 4 |
| Shanghai Proton and Heavy Ion Center | 4 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 4 |
| First Affiliated Hospital Xi'an Jiaotong University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 109 |
| Colonic Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Disease | 5 |
| Pancreatic Neoplasms | 5 |
| Urinary Bladder Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Renal Cell | 3 |
Trials
Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.